Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Up in smoke

The side-lining of efficacy in medical cannabis debates

- PMLiVE

Another setback for Teva’s laquinimod in MS

Side effects seen in two late-stage trials but development will continue

- PMLiVE

Baxalta inks $1.6bn immuno-oncology deal with Symphogen

Comes as the company's takeover negotiations with Shire continue

- PMLiVE

Ariad appoints new CEO

Paris Panayiotopoulos joins the US biotech from EMD Serono

Caligor Rx appoints Michael Dallmann as director of strategic planning

He brings experience from Cubist Pharmaceuticals and Peninsula Pharmaceuticals

- PMLiVE

Glenn Sblendorio to retire as president of The Medicines Company

He will be replaced as chief financial officer by William O’Connor

Shire Basingstoke

Shire deal with Baxalta predicted this week

Takeover talks reported to be at an advanced stage

- PMLiVE

Dr Hamina Patel moves from J&J to Evgen Pharma

She joins the drug development company as its chief medical officer

- PMLiVE

Chimerix hit as lead drug brincidofovir flunks trial

Antiviral failed to meet its objectives in late-stage study

- PMLiVE

KaloBios files for bankruptcy protection

San Francisco biopharma's shares imploded in the wake of Martin Shkreli's arrest

Doctor doctor, where are all the men?

New data show that half of men put off visiting the doctor. Why is this and what can be done to prevent it?

Say Communications

Sanofi reception

Sanofi uses priority review voucher for diabetes combo

LixiLan in race with Xultophy in bid to hit US market first

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links